Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology total assets
Total assets on the balance sheet at the end of each period.
Nexalin Technology's total assets was $3.00M at Jun 30, 2026. For fiscal 2025 it was $4.64M, up 9.8% from the year before. The highest annual figure on record is $7.43M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.64M | +9.8% |
| FY2024 | Dec 31, 2024 | $4.22M | +16.3% |
| FY2023 | Dec 31, 2023 | $3.63M | -51.1% |
| FY2022 | Dec 31, 2022 | $7.43M | +886.1% |
| FY2021 | Dec 31, 2021 | $753.70K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.00M | -54.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.69M | +27.4% |
| Q4 FY2025 | Dec 31, 2025 | $4.64M | +9.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.13M | -2.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.56M | +319.9% |
| Q1 FY2025 | Mar 31, 2025 | $2.90M | +2.3% |
| Q4 FY2024 | Dec 31, 2024 | $4.22M | +16.3% |
| Q3 FY2024 | Sep 30, 2024 | $5.26M | +1.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.56M | -73.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.83M | -61.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.63M | -56.5% |
| Q2 FY2023 | Jun 30, 2023 | $5.18M | +586.7% |
| Q1 FY2023 | Mar 31, 2023 | $5.93M | – |
| Q4 FY2022 | Dec 31, 2022 | $7.43M | – |
| Q3 FY2022 | Sep 30, 2022 | $8.35M | – |
| Q4 FY2021 | Dec 31, 2021 | $753.70K | – |
See a number that looks wrong?